SEC Form 4 · accession 0001209191-18-003069
VICAL INC · VICL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mammen Mammen
Officer — Sr VP, Clinical Development
Period of report
Jan 8, 2018
Accepted (ET)
Jan 10, 2018 · 11:29 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000819050
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.81 | Jan 8, 2018 | A | 57,158 | A | Jan 8, 2019 | Jan 7, 2028 | Common Stock | 57,158 | 57,158 | D |
| Nonstatutory Stock Option (right to buy)F1 | $1.81 | Jan 8, 2018 | A | 12,842 | A | Jan 8, 2019 | Jan 7, 2028 | Common Stock | 12,842 | 12,842 | D |
Explanation of responses
- F1The right to exercise the above stock option generally vests one-fourth on the first anniversary of the grant, with the remaining rights vesting quarterly over the remaining three years.